Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1992 2
1994 1
2001 2
2002 1
2003 1
2004 1
2005 1
2008 1
2009 1
2010 1
2011 1
2012 2
2015 1
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis.
D'Argenio G, Cosenza V, Riegler G, Della Valle N, Deritis F, Mazzacca G; Gruppo Italiano per lo Studio del Colon e del Retto (GISC). D'Argenio G, et al. Dig Dis Sci. 2001 Mar;46(3):649-57. doi: 10.1023/a:1005680022573. Dig Dis Sci. 2001. PMID: 11318547
We found that transglutaminase levels are decreased in serum of patients with inflammatory bowel diseases and demonstrated in a rat model of chronic colitis that serum transglutaminase is closely related to the severity of intestinal damage. We aimed, therefore, to correla …
We found that transglutaminase levels are decreased in serum of patients with inflammatory bowel diseases and demonstrated in a rat model of …
Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.
Andersson C, Kvist PH, McElhinney K, Baylis R, Gram LK, Pelzer H, Lauritzen B, Holm TL, Hogan S, Wu D, Turpin B, Miller W, Palumbo JS. Andersson C, et al. PLoS One. 2015 Jun 22;10(6):e0128113. doi: 10.1371/journal.pone.0128113. eCollection 2015. PLoS One. 2015. PMID: 26098308 Free PMC article.
Consistent with prior evidence of ongoing coagulation factor activation and consumption in individuals with active colitis, plasma FXIII levels were markedly decreased in colitis-challenged WT mice. ...These findings directly demonstrate that FXIII is a significant …
Consistent with prior evidence of ongoing coagulation factor activation and consumption in individuals with active colitis, plasma FX …
Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
D'Argenio G, Cosenza V, Sorrentini I, De Ritis F, Gatto A, Delle Cave M, D'Armiento FP, Mazzacca G. D'Argenio G, et al. Gastroenterology. 1994 Feb;106(2):399-404. doi: 10.1016/0016-5085(94)90598-3. Gastroenterology. 1994. PMID: 7905450
BACKGROUND/AIMS: Butyrate and factor XIII may improve ulcerative colitis; they also affect tissue and serum transglutaminase levels. We investigated the therapeutic potential of sodium butyrate and factor XIII and the role of transglutaminase during mucosal repair in exper …
BACKGROUND/AIMS: Butyrate and factor XIII may improve ulcerative colitis; they also affect tissue and serum transglutaminase levels. …
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, Paoluzi P, Picarelli A. Di Tola M, et al. Clin Chem Lab Med. 2004;42(10):1092-7. doi: 10.1515/CCLM.2004.225. Clin Chem Lab Med. 2004. PMID: 15552265
Study population comprised: 49 patients with Crohn's disease and 29 patients with ulcerative colitis; 45 patients with celiac sprue and 85 autoimmune patients as disease controls; and 58 volunteers as healthy controls. ...Marked increased anti-tissue transglutaminase conce …
Study population comprised: 49 patients with Crohn's disease and 29 patients with ulcerative colitis; 45 patients with celiac sprue a …
Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat.
D'Argenio G, Sorrentini I, Cosenza V, Gatto A, Iovino P, D'Armiento EP, Baldassarre F, Mazzacca G. D'Argenio G, et al. Scand J Gastroenterol. 1992;27(2):111-4. doi: 10.3109/00365529209165428. Scand J Gastroenterol. 1992. PMID: 1348588
The results showed a reduced TG activity in colon of rats in both acute and chronic induced colitis (447 +/- 75 versus 1344 +/- 59 mU/g protein (p less than 0.001) and 484 +/- 59 versus 1204 +/- 75 mU/g protein (p less than 0.001)). This decreased activity was related to t …
The results showed a reduced TG activity in colon of rats in both acute and chronic induced colitis (447 +/- 75 versus 1344 +/- 59 mU …
IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.
Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. Bizzaro N, et al. Dig Dis Sci. 2003 Dec;48(12):2360-5. doi: 10.1023/b:ddas.0000007875.72256.e8. Dig Dis Sci. 2003. PMID: 14714625
Among the 12 patients and the healthy subject, only 2 (1 SLE and 1 ulcerative colitis patient) were subsequently confirmed to be affected with CD by positive EMA, HLA, and small bowel biopsy findings. ...
Among the 12 patients and the healthy subject, only 2 (1 SLE and 1 ulcerative colitis patient) were subsequently confirmed to be affe …
Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease.
Sjöber K, Eriksson S, Tenngart B, Roth EB, Leffler H, Stenberg P. Sjöber K, et al. Autoimmunity. 2002 Aug;35(5):357-64. doi: 10.1080/73-0891693021000005402. Autoimmunity. 2002. PMID: 12515290
We compared titres of both IgA- and IgG-antibodies against these two antigens in 20 CD patients, 20 endomysial antibody (EMA)-negative controls and a group with inflammatory bowel disease (34 with Crohn's disease and 23 with ulcerative colitis). IgA-antibodies against tTg …
We compared titres of both IgA- and IgG-antibodies against these two antigens in 20 CD patients, 20 endomysial antibody (EMA)-negative contr …
Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.
D'Argenio G, Calvani M, Della Valle N, Cosenza V, Di Matteo G, Giorgio P, Margarucci S, Petillo O, Jori FP, Galderisi U, Peluso G. D'Argenio G, et al. Gut. 2005 Apr;54(4):496-502. doi: 10.1136/gut.2004.049411. Gut. 2005. PMID: 15753534 Free PMC article.
BACKGROUND AND AIMS: Ulcerative colitis (UC) is characterised by refractory inflammatory ulceration and damage to the colon. ...As transglutaminase expression resulting in matrix protein cross linking is associated with increased wound healing in a rat model of colitis
BACKGROUND AND AIMS: Ulcerative colitis (UC) is characterised by refractory inflammatory ulceration and damage to the colon. ...As tr …
Serum transglutaminase in inflammatory bowel diseases.
D'Argenio G, Cicacci C, Sorrentini I, Iovino P, Gatto A, Cosenza V, Mazzacca G. D'Argenio G, et al. J Clin Gastroenterol. 1990 Aug;12(4):400-4. doi: 10.1097/00004836-199008000-00009. J Clin Gastroenterol. 1990. PMID: 1975816
There were 49 patients with Crohn's disease (CD), 50 with ulcerative colitis (UC), 35 with diseases other than IBD as control group and 42 healthy subjects matched for sex and age. ...
There were 49 patients with Crohn's disease (CD), 50 with ulcerative colitis (UC), 35 with diseases other than IBD as control group a …
Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis.
Jeong EM, Son YH, Choi Y, Kim JH, Lee JH, Cho SY, Kim IG. Jeong EM, et al. Exp Mol Med. 2016 Nov 4;48(11):e267. doi: 10.1038/emm.2016.95. Exp Mol Med. 2016. PMID: 27811936 Free PMC article.
In this study, we investigated the role of TG2 in dextran sulfate sodium (DSS)-induced colitis, the most widely used mouse model for IBD. Age- and sex-matched wild-type and TG2(-/-) mice were fed 2% DSS for 7 days or 3.5% DSS for 5 days in drinking water. ...These results …
In this study, we investigated the role of TG2 in dextran sulfate sodium (DSS)-induced colitis, the most widely used mouse model for …
17 results